A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Potassium cation
Normethadone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Normethadone.
Potassium cation
Thiocolchicoside
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiocolchicoside.
Potassium cation
Detomidine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Detomidine.
Potassium cation
Zolazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zolazepam.
Potassium cation
Tricaine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tricaine.
Potassium cation
Tiletamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tiletamine.
Potassium cation
Romifidine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Romifidine.
Potassium cation
Propiopromazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Propiopromazine.
Potassium cation
Xylazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Xylazine.
Potassium cation
Medetomidine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Medetomidine.
Potassium cation
Doramectin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Doramectin.
Potassium cation
Azaperone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Azaperone.
Potassium cation
Alfaxalone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alfaxalone.
Potassium cation
Pyrantel
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pyrantel.
Potassium cation
Opium
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Opium.
Potassium cation
Oxaprotiline
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxaprotiline.
Potassium cation
Ramosetron
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ramosetron.
Potassium cation
Tianeptine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tianeptine.
Potassium cation
Pipamperone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pipamperone.
Potassium cation
Caroxazone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Caroxazone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3